Exploring Immunotherapy in Small Cell Lung Cancer

Janice M. Mehnert, MD, director of the Phase I/Investigational Therapeutics Program at Rutgers Cancer Institute of New Jersey, is among the investigators collaborating on research examining the anti-PD-1 therapy drug pembrolizumab in small cell lung cancer. Learn more

Janet Mehnert photo

New Jersey’s Only

Rutgers Cancer Institute, the state’s only Comprehensive Cancer Center as designated by the National Cancer Institute, has been awarded a $15.1 million grant as part of its successful redesignation. New Jersey Governor Phil Murphy, 10-year old cancer survivor Grace Eline and other dignitaries shared what that means for the Garden State. Learn more


Bringing research to life: From genetic implications to exploring the impact of self-cannibalization of cancer cells, scientists at Rutgers Cancer Institute work in concert with our physicians to translate cancer discoveries into today’s treatments.

Female researcher working in the lab at Rutgers Cancer Institute of New Jersey

Research Overview

Female researcher working in the lab at Rutgers Cancer InstituteRutgers Cancer Institute of New Jersey's physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, outsmarting cancer with science.

Rutgers Cancer Institute of New Jersey is a matrix style, basic, clinical and population research center as well as a consortium cancer center with Rutgers University and Princeton University leveraging the science of the state's cancer researchers through collaboration. Rutgers Cancer Institute of New Jersey is sharply focused on fulfilling the cancer research needs of the most densely populated and industry rich state in the nation.

Rutgers Cancer Institute of New Jersey research programs and core facilities enhance and support the cancer research of more than 230 members at Rutgers University, Princeton University and the Institute for Advanced Study in Princeton.

Basic and Clinical Research Program Newsletters

Cancer Prevention and Control Program Newsletters

Research is currently being conducted in areas including: population science, precision medicine, systems biology, oncogenesis, tumor virology and immunology, autophagy, drug development and resistance, the relationship between cellular and genetic alterations and tumor development, cancer control and prevention, bioinformatics, and cancer genomics.

Rutgers Cancer Institute of New Jersey continues to expand its foundation of knowledge and the technical tools with which rapid advances can be made in understanding the mechanisms of cancer.  Opportunities to manage the disease have increased and clinical research studies have yielded results that will have a profound effect in the prevention and treatment of many cancers.

Important Links

Rutgers Cancer Institute of New Jersey Research Programs

Rutgers Cancer Institute of New Jersey Shared Resources

Calendar of Research Program Meetings, Lectures and Other Events for Rutgers Cancer Institute of New Jersey Members

Collage of researchers working at Rutgers Cancer Institute in labs.




image that says give now and support cancer research with link to giving page





Robert Wood Johnson Barnabas Health logo with link to Partners page





ScreenNJ logo with link to website






Big Ten Cancer Research Consortium





Rutgers Health